Fowl Cholera in Poultry: Etiology, Clinical Signs, and Control

Introduction

Fowl cholera, also termed avian pasteurellosis or avian cholera, is a highly contagious and economically significant septicemic bacterial disease affecting a wide range of avian species, including chickens, turkeys, ducks, geese, and game birds [1, 2, 3]. The disease is caused by the gram-negative coccobacillus Pasteurella multocida [4, 5]. Fowl cholera remains a persistent threat to global poultry production, causing substantial morbidity and mortality in both commercial and backyard flocks [2, 6]. This article provides a detailed, publication-grade review of the etiology, epidemiology, clinical signs, pathology, diagnostic approaches, treatment, and control measures for fowl cholera in poultry, with a specific focus on integrating relevant terminology and concepts for a broad veterinary audience.

Etiology

Causative Agent

The etiologic agent of fowl cholera is Pasteurella multocida, a small, non-motile, gram-negative, facultatively anaerobic bacterium [3, 5]. P. multocida is a member of the family Pasteurellaceae [5]. The bacterium is typically observed as a coccobacillus or short rod, often exhibiting bipolar staining when treated with Giemsa or methylene blue stains [5]. The organism is encapsulated, and the capsule is a critical virulence determinant [3]. P. multocida is classified into multiple serotypes based on capsular and lipopolysaccharide (LPS) antigens. The capsular serogroups are designated A, B, D, E, and F, with serogroup A being the most common cause of fowl cholera in poultry [3, 5]. LPS serotypes are classified as L1 through L8 [7, 8]. Specific virulence factors include the capsule (capA), iron acquisition proteins (exbB, hgbB, fur), fimbriae and adhesins (fim4, fimA, pfhA, tadD), outer membrane proteins (oma87, plpB), sialidases (nanB, nanH), and superoxide dismutases (sodA, sodC) [3].

Virulence Factors and Pathogenesis

The pathogenesis of P. multocida is multifactorial, relying on a suite of virulence-associated genes (VAGs) [3, 9]. The bacterium's ability to evade host immune defenses and establish infection is mediated by its capsule, which inhibits phagocytosis [3]. Adhesion to host epithelial cells is facilitated by fimbriae and other adhesins [3]. Iron acquisition systems, including those encoded by exbB, hgbB, and fur, are essential for bacterial survival within the host, as iron is sequestered by host proteins [3]. The production of sialidases (nanB, nanH) aids in the cleavage of sialic acid from host cell surfaces, potentially facilitating immune evasion and tissue invasion [3]. The presence of a toxA gene is variable among isolates; notably, some studies have reported its absence in fowl cholera isolates [3]. The P. multocida genome also encodes for phase variation mechanisms, particularly in glycosyltransferase genes involved in LPS outer core biosynthesis, which can alter the bacterial surface and influence vaccine efficacy [7].

Epidemiology

Host Range and Susceptibility

Fowl cholera affects a broad spectrum of avian species [1, 10]. Chickens, turkeys, ducks, and geese are highly susceptible [11]. Turkeys are particularly vulnerable to acute, fulminant disease [12]. Waterfowl, including wild birds, can serve as reservoirs for P. multocida, contributing to the transmission of the bacterium to domestic poultry flocks [10, 11]. The disease is often associated with wetlands, which act as environmental reservoirs [11]. Outbreaks in wild birds can lead to spillover events into commercial poultry operations [10].

Transmission and Risk Factors

Transmission of P. multocida occurs primarily through direct contact between infected and susceptible birds, via respiratory secretions, and through contaminated feed, water, and fomites [5, 13]. The bacterium can also be transmitted through the oral route [14]. P. multocida can inhabit the upper respiratory tract of many avian species as a commensal organism, and stress factors such as cold and wet weather, overcrowding, poor ventilation, nutritional deficiencies, and concurrent infections can precipitate disease outbreaks [11, 13]. The basic reproduction number (R0) for fowl cholera transmission in poultry flocks has been modeled using a susceptible-exposed-symptomatic-asymptomatic-treated-culled-recovered (SEIATCR) framework, with the R0 being influenced by transmission rate, vaccine efficacy, and treatment rate [13]. Environmental factors, including vaccination gaps and bird age, are significant predictors of infection status [2].

Geographic Distribution

Fowl cholera has a worldwide distribution, with reported outbreaks in Asia, Africa, Europe, North America, and Australia [3, 4, 15, 16, 9]. In Taiwan, the occurrence of fowl cholera in poultry flocks has been documented [15]. In Ethiopia, the disease is a major constraint to poultry production, with a high prevalence in layer and breeder flocks [5, 17]. In Bangladesh, multidrug-resistant P. multocida type B:2 has been isolated from laying hens [9]. In Indonesia, P. multocida isolates from layer chickens have been characterized for antibiotic resistance and virulence gene profiles [3]. In Korea, multilocus sequence typing (MLST) has identified sequence types (STs) 134, 366, and 374 in acute fowl cholera outbreaks [8].

Clinical Signs

The clinical presentation of fowl cholera can be classified into acute, subacute, and chronic forms [6, 18]. The acute form is characterized by sudden onset with high morbidity and mortality, while the chronic form is associated with localized infections [18].

Acute Form

In the acute form, infected birds may die within 8 to 12 hours after contracting the bacterium, often without premonitory signs [11]. Clinical signs, when observed, include fever, ruffled feathers, depression, anorexia, and mucus discharge from the mouth [18]. Affected birds may exhibit increased respiratory rate, cyanosis of the comb and wattles, and diarrhea, which is often greenish or yellowish [18]. In laying flocks, a sudden drop in egg production is a common sign [19].

Chronic Form

The chronic form of fowl cholera may follow an acute stage or present as the primary manifestation of disease in a flock [18]. Chronic infections are characterized by localized lesions, including swollen and edematous wattles (wattle edema), sinusitis, conjunctivitis, and torticollis (twisted neck) due to involvement of the central nervous system [18]. Arthritis and synovitis, leading to lameness and swollen joints, are also common in chronic cases [6, 18]. Rales (respiratory sounds) and pin-headed necrotic foci in the liver are additional findings [18].

Fowl Cholera in Hindi Terminology

For veterinary professionals working in Hindi-speaking regions, the clinical signs of fowl cholera are described using specific terminology. The acute form is often referred to as "तीव्र फाउल कॉलरा" (tivra fowl cholera), with signs including "बुखार" (bukhār, fever), "पंख फड़फड़ाना" (pankh faṛfaṛānā, ruffled feathers), "मुँह से बलगम" (muh se balgam, mucus from mouth), "दस्त" (dast, diarrhea), and "तेजी से मृत्यु" (tejī se mṛtyu, sudden death). The chronic form is termed "जीर्ण फाउल कॉलरा" (jīrṇ fowl cholera), with signs such as "गले की सूजन" (gale kī sūjan, wattle swelling), "जोड़ों का दर्द" (joṛo kā dard, joint pain), and "लंगड़ापन" (langṛāpan, lameness). The term "फाउल कॉलरा" (fowl cholera) is used directly in Hindi veterinary contexts.

Pathology

Gross Lesions

Postmortem examination of birds succumbing to acute fowl cholera reveals characteristic gross lesions [6]. These include multifocal necrosis in the liver, which appears as small, pale, pinhead-sized foci [6, 18]. Hemorrhages are observed in multiple internal organs, including the heart (epicardial and myocardial), lungs, and serosal surfaces [6]. The lungs may exhibit edema and congestion [6]. Ascites (fluid accumulation) in the thoracic and abdominal cavities is a common finding in acute cases [6]. Arthritis, particularly in the hock and wing joints, is a hallmark of chronic disease [6]. In turkeys, acute heart rupture, with blood clots expanding the pericardium and a tear in the left ventricular free wall, has been documented as an atypical presentation [12]. Vegetative valvular lesions (aortic valvulitis) can lead to septic embolization and infarction in multiple organs [12].

Histopathological Lesions

Histopathological examination reveals characteristic lesions that confirm the diagnosis [6]. Vasculitis, with fibrinoid necrosis and infiltration of inflammatory cells, is a prominent feature [6]. Submucosal edema in the trachea is observed [6]. Multifocal necrosis in the liver is characterized by coagulative necrosis and the presence of bacterial colonies [6]. Desquamation of intestinal villi, with loss of epithelial integrity, is a common finding [6]. In the spleen and kidney, infarcts are observed [12]. The presence of large numbers of gram-negative bacterial colonies in multiple organs is a hallmark of septicemia [12].

Diagnostics

Bacteriological Isolation and Identification

Definitive diagnosis of fowl cholera relies on the isolation and identification of P. multocida from clinical specimens [4, 5]. Samples from acutely dead or moribund birds, including tracheal swabs, lung, liver, spleen, and bone marrow, are preferred [4, 6]. The bacterium is cultured on blood agar or MacConkey agar (where it does not grow) [3]. On blood agar, P. multocida produces small, gray, non-hemolytic colonies with a characteristic "musty" odor [3]. Gram staining reveals gram-negative coccobacilli [3]. Biochemical tests, including catalase, oxidase, and indole production, are used for preliminary identification [4].

Molecular Diagnostics

Molecular techniques, particularly polymerase chain reaction (PCR), are the gold standard for confirmatory diagnosis and genotyping [4, 5]. Capsular serotype-specific PCR, targeting the capA gene, is used to identify serogroup A isolates [4]. LPS genotyping, using PCR targeting the outer core biosynthesis loci, is used to differentiate LPS types (L1-L8) [5, 7]. Multilocus sequence typing (MLST) provides high-resolution genotyping for epidemiological investigations [8]. Whole-genome sequencing (WGS) and phylogenomic analysis are increasingly used to investigate outbreak dynamics, identify virulence factors, and assess antimicrobial resistance (AMR) gene content [7, 9]. Random amplification of polymorphic DNA (RAPD) analysis is used to differentiate P. multocida strains [9].

Serological Assays

Serological assays, including enzyme-linked immunosorbent assays (ELISAs), are used to monitor antibody responses in vaccinated flocks [17, 20]. Indirect ELISA and sandwich ELISA are used to quantify serum IgG and secretory IgA levels, respectively [17]. The hemagglutination test has been used to assess antibody titers in response to vaccination [19].

Predictive Modeling and Data Mining

Advanced data mining and machine learning algorithms, including logistic regression, random forest, and gradient boosting, have been developed to predict fowl cholera infection status in poultry [2]. These models use variables such as bird age, vaccination history, environmental conditions, clinical symptoms, and mortality rates to achieve high predictive accuracy (e.g., 94.6% with random forest) [2]. This approach represents a transformative tool for veterinary epidemiology and flock health management.

Treatment

Antimicrobial Therapy

Antimicrobial therapy is a critical component of fowl cholera management in acute outbreaks [3, 4]. Antibiotic susceptibility testing (AST), using the Kirby-Bauer disk diffusion method or automated systems, is essential to guide treatment [3, 4]. P. multocida isolates generally show susceptibility to penicillin, ampicillin, norfloxacin, and florfenicol [4]. However, resistance to fluoroquinolones (e.g., levofloxacin, ciprofloxacin) has been reported [3]. Multidrug-resistant (MDR) strains, particularly those of type B:2, have been identified, harboring a range of antimicrobial resistance genes (ARGs) [9, 21]. The use of bacteriophage lysates has been explored as an alternative therapeutic approach [22].

Supportive Care

Supportive care, including provision of clean water, high-quality feed, and reduction of stress, is critical for recovery [13]. In acute outbreaks, prompt treatment of the entire flock with water-soluble antibiotics is recommended, followed by a withdrawal period as per regulatory guidelines.

Control

Vaccination

Vaccination is the most effective strategy for controlling fowl cholera in endemic areas [1, 23, 17]. Both inactivated (killed) and live vaccines are available [1, 17]. Formalin-inactivated vaccines, administered intramuscularly, are widely used but have variable efficacy [17]. Gamma-irradiated vaccines, which are inactivated using ionizing radiation, have demonstrated superior immunogenicity, inducing both systemic and mucosal antibody responses and a Th1-dominant cellular response [17, 24]. Bivalent inactivated vaccines, combining P. multocida with avian influenza virus antigens, have been developed to provide dual protection [1, 23]. Autogenous vaccines, prepared from farm-specific P. multocida isolates, are used in free-range production systems [7]. Iron-inactivated vaccines, using iron-restricted culture conditions, have shown enhanced protective efficacy [20, 25]. Biofilm-based vaccines have also been evaluated [26]. The use of novel multi-strain probiotics has been shown to reduce P. multocida colonization and mortality in broilers [14].

Biosecurity

Strict biosecurity measures are essential to prevent the introduction and spread of P. multocida [5]. These include all-in/all-out flock management, disinfection of premises and equipment, rodent and wild bird control, and quarantine of new birds [5]. Proper disposal of dead birds and manure is critical [5].

Culling and Quarantine

In the event of an outbreak, culling of infected and exposed birds, followed by depopulation and cleaning of the facility, is recommended [13]. Quarantine of affected premises is enforced to prevent movement of birds and fomites [13].

Conclusion

Fowl cholera, caused by Pasteurella multocida, remains a significant threat to global poultry production. The disease is characterized by acute septicemia with high mortality or chronic localized infections. Accurate diagnosis relies on bacteriological culture, molecular typing, and advanced predictive modeling. Effective control requires a combination of vaccination, biosecurity, and targeted antimicrobial therapy, guided by susceptibility testing. The integration of genomic epidemiology and data-driven predictive tools will enhance the management of this economically important disease.

References

[1] Rafique, M., Shahzad, A., Jahangir, G., et al. Immunopotential of the Combine Vaccine against Fowl Cholera and Avian Influenza Virus in Poultry. Molecular Genetics Microbiology and Virology, 2025.

[2] Amosa, B. M. G., Onyeka, N.C., Fabiyi, A. O., et al. Development of a Predictive Model for Fowl-Cholera Infection Status in Poultry Using Advanced Data Mining Analysis Techniques and Logistic Regression Modeling. International Journal of Latest Technology in Engineering Management & Applied Science, 2026.

[3] Arvia, M. M., Kurnia, R., Nugroho, C., et al. Characterization of Pasteurella multocida Isolated from Layer Chickens Infected with Fowl Cholera in Sukabumi, Indonesia: Antibiotic Resistance and Virulence Gene Detection. World's Veterinary Journal, 2025.

[4] Geda, A. M., Wendimu, A., Lulie, S., et al. Molecular Detection and Antibiogram Profiling of Pasteurella multocida Isolated From Breeder Chickens Suspected of Fowl Cholera in Gondar City, Ethiopia. International Journal of Microbiology, 2025.

[5] Geda, A. M. Fowl Cholera in Chickens: Current Trends in Diagnosis and Phenotypic Drug Resistance in Gondar City, Ethiopia. Veterinary Medicine International, 2024.

[6] Aliza, D., Hasan, D., Nazaruddin, N., et al. Diagnosis of Fowl Cholera in Broiler Chicken Collected from Banda Aceh and Aceh Besar. Jurnal Medika Veterinaria, 2024.

[7] Omaleki, L., Blackall, P., Cuddihy, T. P., et al. Phase variation in the glycosyltransferase genes of Pasteurella multocida associated with outbreaks of fowl cholera on free-range layer farms. Microbial Genomics, 2022.

[8] Lai, V. D., Kim, J. S., Mo, I. Multilocus Sequence Typing of Pasteurella multocida Isolates from Acute Fowl Cholera Outbreak in Layer. Korean Journal of Poultry Science, 2020.

[9] Saha, O., Islam, M. R., Rahman, M. S., et al. First report from Bangladesh on genetic diversity of multidrug-resistant Pasteurella multocida type B:2 in fowl cholera. Veterinary World, 2021.

[10] Petersen, K. D., Christensen, J., Permin, A., et al. Virulence of Pasteurella multocida subsp. multocida isolated from outbreaks of fowl cholera in wild birds for domestic poultry and game birds. Avian Pathology, 2001.

[11] Hassan, N., Hamadani, H., Zargar, U. R. Rare Outbreak of Fowl Cholera in Waterfowls in Dal Lake Area of Kashmir, with Isolation, Antibiogram and Successful Treatment - A Report. Journal, 2017.

[12] Blakey, J., Crispo, M., Bickford, A., et al. Fowl cholera and acute heart rupture in a backyard turkey. Journal of Veterinary Diagnostic Investigation, 2019.

[13] Malek, A. Dynamics of cholera transmission in poultry farm: insights from a compartmental model and control strategies. British Poultry Science, 2025.

[14] Reuben, R., Sarkar, S., Ibnat, H., et al. Novel multi-strain probiotics reduces Pasteurella multocida induced fowl cholera mortality in broilers. Scientific Reports, 2021.

[15] Tsai, H. J., You, W. B. Short communication. Occurrence of fowl cholera in poultry flocks in Taiwan. Journal, 2000.

[16] Kardos, G., Kiss, I. Molecular Epidemiology Investigation of Outbreaks of Fowl Cholera in Geographically Related Poultry Flocks. Journal of Clinical Microbiology, 2005.

[17] Belay, E., Bitew, M., Ibrahim, S. M., et al. Gamma-irradiated fowl cholera vaccines formulated with different adjuvants induced antibody response and cytokine expression in chickens. Frontiers in Immunology, 2025.

[18] Salama, S., Fatma, M., Gadallah, G., et al. Uses of single dose dependent and relative potency assays for the evaluation of inactivated fowl cholera vaccine. Journal of Bacteriology & Mycology: Open Access, 2019.

[19] Hegazy, S., Azzam, A., Gabal, M. A. Interaction of naturally occurring aflatoxins in poultry feed and immunization against fowl cholera. Poultry Science, 1991.

[20] Abhilash, M., Kannaki, T., Priyanka, E., et al. Immunogenicity and Protective Efficacy of Iron-inactivated Pasteurella multocida A:1 Vaccine against Fowl Cholera in Backyard Chicken. Indian Journal of Animal Research, 2021.

[21] Saha, O., Islam, M. R., Rahman, M. S., et al. Genome-wide diversity and differentiation of two novel multidrug-resistant populations of Pasteurella multocida type B:2 from fowl cholera. bioRxiv, 2020.

[22] Ramchandran, D., Verma, H., Prajapati, A., et al. Application of bacteriophage lysate for treatment of fowl cholera in poultry. Journal, 2012.

[23] Ahsan, M., Jalees, M. M., Ashraf, W., et al. Immunization Potency and Protective Efficacy of a Bivalent Inactivated Fowl Cholera and Avian Influenza Vaccine in Poultry. Journal of Population Therapeutics and Clinical Pharmacology, 2024.

[24] Dessalegn, B., Bitew, M., Asfaw, D., et al. Gamma-Irradiated Fowl Cholera Mucosal Vaccine: Potential Vaccine Candidate for Safe and Effective Immunization of Chicken Against Fowl Cholera. Frontiers in Immunology, 2021.

[25] Luo, Q., Kong, L., Dong, J., et al. Protection of chickens against fowl cholera by supernatant proteins of Pasteurella multocida cultured in an iron-restricted medium. Avian Pathology, 2019.

[26] Ramesh, P. T. Comparative Evaluation of Biofilm Vaccine with other Conventional Vaccines Against Fowl Cholera in Poultry Layer Birds. Journal, 2006.

[27] Ookanti, S. Co-infection of Fowl Cholera with bacterial and viral infection in poultry flocks. Journal, null.

[28] Isolation and Molecular Identification of Pasteurella multocida from Commercial Poultry Farms Suffering from Fowl Cholera. International Journal of Biology Pharmacy and Allied Sciences, 2019.

[29] Wickramasinghe, R., Peiris, H. An outbreak of fowl cholera in a poultry farm in Sri Lanka. Journal, 1985.

[30] Kardos, G., Kiss, I. Molecular Epidemiology Investigation of Outbreaks of Fowl Cholera in Geographically Related Poultry Flocks. Journal, 2005.

[31] Wubet, W., Bitew, M., Mamo, G., et al. Evaluation of inactivated vaccine against fowl cholera developed from local isolates of Pasteurella multocida in Ethiopia. Journal, 2019.

[32] Fasina, Y., Suarez, D. L., Ritter, G. D., et al. Unraveling frontiers in poultry health (part 1) – Mitigating economically important viral and bacterial diseases in commercial Chicken and Turkey production. Poultry Science, 2024.

[33] Salama, S., Gadallah, F., Abo-elkhir, F., et al. Uses of Single Dose Dependent and Relative Potency Assays for Evaluation of Inactivated Fowl Cholera Vaccine. The Journal of World's Poultry Research, 2019.

[34] Poolperm, P., Apinda, N., Kataoka, Y., et al. Protection against Pasteurella multocida conferred by an intranasal fowl cholera vaccine in Khaki Campbell ducks. Journal, 2019.

[35] Poolperm, P., Apinda, N., Kataoka, Y., et al. Protection against Pasteurella multocida conferred by an intranasal fowl cholera vaccine in Khaki Campbell ducks. Journal, 2018. *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.